Home›Companies›Biotech & Pharma›Calviri

Calviri Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 12, 2024·Suggest an edit

About Calviri

Calviri is a private company based in Phoenix, Arizona. It has reported $17,401,948 raised in seven offerings on Form D since January 2019. Its chief executive is Stephen Johnston.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 24, 2024Nov 12, 2024$785,004of $5.0M target10$78,500EquityRule 506(b)Form D ↗
Sep 6, 2024Sep 24, 2024$150,000of $2.0M target1$150KEquity, Debt, Unsecured Convertible Promissory NotesRule 506(b)Form D ↗
Sep 20, 2023Oct 4, 2023$650,232of $30.0M target3$216KEquityRule 506(b)Form D ↗
Oct 28, 2021Nov 12, 2021amended May 9, 2023$11,081,708of $11.0M target32$346KEquityRule 506(b)Form D/A ↗1 earlier filing
Sep 24, 2020Oct 20, 2020$2,430,002of $5.0M target5$486KEquityRule 506(b)Form D ↗
Sep 24, 2020Oct 15, 2020$430,002of $5.0M target3$143KEquityRule 506(b)Form D ↗
Dec 20, 2018Jan 7, 2019amended Mar 6, 2020$1,875,000of $2.2M target4$468KEquity, Debt, Unsecured Convertible Promissory NotesRule 506(b)Form D/A ↗1 earlier filing
Total, seven offerings$17,401,948

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Calviri's Form D filed Nov 12, 2024.

KS
SJ
Stephen Johnston
Chief Executive Officer and director
JS

Earlier filings also listed Michael Chambers (director, last listed Oct 2023), Neal Woodbury (director, last listed Mar 2020), George Poste (director, last listed Mar 2020) and Anna Barker (director, last listed Mar 2020).

Sources

  1. SECCALVIRI INC Form D, filed Nov 12, 2021
  2. SECCALVIRI INC Form D, filed Jan 7, 2019
  3. SECCALVIRI INC filing history